
Carbotroy 250mcg Injection
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Carboprost (250mcg)
Overview Carbotroy 250mcg Injection
Postpartum uterine hemorrhage is managed with Carbotroy 250mcg Injection, a medication that promotes uterine muscle contractions to reduce excessive bleeding. Administered intramuscularly by a physician in a hospital setting only, self-injection is strictly prohibited. Common side effects such as nausea, facial flushing, cephalgia, and shivering may occur; inform your doctor if these are bothersome or severe, as mitigating strategies exist. Dizziness warrants avoidance of driving and activities requiring concentration. Prior to administration, disclose any pre-existing cardiovascular disease, hypertension or hypotension, hepatic or renal impairment, and all other medications currently in use, as interactions may affect Carbotroy's efficacy. This injection is exclusively for postpartum use; it is contraindicated during pregnancy.
Primary Ingredients of Carbotroy 250mcg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Carbotroy 250mcg Injection
Hemorrhage postpartum
Major Benefits of Carbotroy 250mcg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Carbotroy 250mcg Injection:
- Nausea
- Vomiting
- Headache
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hot flashes
- Diarrhea
- Chills
- Placental retention
- Cough
How to use Carbotroy 250mcg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
How Carbotroy 250mcg Injection works:
Uterine muscle contraction is induced by Carbotroy 250mcg Injection, thereby managing postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carbotroy 250mcg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Carbotroy 250mcg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, as research in both animal and human subjects indicates considerable harm to the fetus.
Breast feedingCAUTION
The administration of Carbotroy 250mcg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Carbotroy 250mcg Injection may induce adverse reactions that impair driving capabilities. This is because Carbotroy 250mcg Injection can cause dizziness, drowsiness, or loss of consciousness, thereby affecting the ability to operate a vehicle.
KidneyCAUTION
Administering Carbotroy 250mcg Injection requires careful consideration in individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised. Carbotroy 250mcg Injection is contraindicated in patients experiencing active kidney disease.
LiverCAUTION
Patients with liver impairment should use Carbotroy 250mcg Injection cautiously, potentially requiring dose modification. A physician's consultation is advised. Carbotroy 250mcg Injection is contraindicated in individuals experiencing active liver disease.
What if you forget to take Carbotroy 250mcg Injection :
NA
Facts to Know About Carbotroy 250mcg Injection
| Label | Value |
|---|---|
| Chemical Category | Prostaglandin Analog |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
